Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
CASI Pharmaceuticals
AddedFeb 19, 2024
UpdatedJul 4, 2026
CASI Pharmaceuticals

CASI Pharmaceuticals

Public

US-based biopharmaceutical firm offering cost-effective, innovative oncology treatments and pharmaceuticals.

HQ
Rockville, MD, US
Founded
1991
Overview
Compare
Fundraising
Employees
Website

Casi Pharmaceuticals is a US-based biopharmaceutical company focused on delivering high-quality, cost-effective pharmaceutical products and innovative oncology therapeutics. The company specializes in hematologic malignancies and other unmet medical needs. Casi Pharmaceuticals offers a robust pipeline of commercially available and clinical-stage drug candidates, continually acquiring assets to expand its portfolio. The firm is dedicated to exploring therapies that save patients' lives.

Among its key achievements, Casi Pharmaceuticals launched EVOMELA® in China as its first commercial product. This milestone underscores the company's commitment to expanding its global footprint and addressing critical healthcare needs. The firm's impact is significant in the oncology sector, providing essential treatments and advancing medical research. Casi Pharmaceuticals continues to grow its influence through strategic acquisitions and a strong focus on innovative therapeutic solutions.

CASI Pharmaceuticals - Similar Companies

CBA Pharma logo

CBA Pharma

cbapharma.com

Karyopharm Therapeutics logo

Karyopharm Therapeutics

karyopharm.com

Cullinan Oncology logo

Cullinan Oncology

OnCusp Therapeutics logo

OnCusp Therapeutics

oncusptx.com

Citius Pharmaceuticals logo

Citius Pharmaceuticals

citiuspharma.com

Cass Pharmaceuticals logo

Cass Pharmaceuticals

casspharma.com

G1 Therapeutics logo

G1 Therapeutics

g1therapeutics.com

BeOne Medicines logo

BeOne Medicines

beigene.com

Accelerated Pharma logo

Accelerated Pharma

Camino Pharma logo

Camino Pharma

caminopharma.com

Novita Pharmaceuticals logo

Novita Pharmaceuticals

novita-pharm.com

Revolution Medicines logo

Revolution Medicines

revmed.com

Clovis Oncology logo

Clovis Oncology

Traws Pharma logo

Traws Pharma

Artisan Pharma logo

Artisan Pharma

CASI Pharmaceuticals - Quick Facts

Who are CASI Pharmaceuticals' competitors?

Companies similar to CASI Pharmaceuticals include CBA Pharma, Karyopharm Therapeutics, Cullinan Oncology and OnCusp Therapeutics.

When was CASI Pharmaceuticals founded?

CASI Pharmaceuticals was founded in 1991.

Where is CASI Pharmaceuticals' headquarters located?

CASI Pharmaceuticals' headquarters is located in Rockville, MD, US.

When was CASI Pharmaceuticals' last funding round?

CASI Pharmaceuticals' most recent funding round was for $32.5M (USD) in March 2021.

How much has CASI Pharmaceuticals raised to-date?

As of Mar 24, 2021, CASI Pharmaceuticals has raised a total of $185.4M (USD).

How many employees does CASI Pharmaceuticals have?

CASI Pharmaceuticals has 224 employees as of Feb 6, 2024.

CASI Pharmaceuticals - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Oncology Therapeutics
Tags
  • Financial
  • Healthcare
  • Pharma
Unique IDs
  • secCik: 0001962738
  • ticker: CASIF
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 14 more industry codes
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 620000Health Care and Social Assistance
  • 541000Professional, Scientific, and Technical Services
  • 623000Nursing and Residential Care Facilities
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 4000Railroad Transportation
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research